# An Efficacy and Safety Study of HGT-1110 in Participants With Metachromatic Leukodystrophy

> **NCT01887938** · PHASE1,PHASE2 · COMPLETED · sponsor: **Shire** · enrollment: 24 (actual)

## Conditions studied

- Metachromatic Leukodystrophy (MLD)

## Interventions

- **BIOLOGICAL:** HGT-1110

## Key facts

- **NCT ID:** NCT01887938
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05-23
- **Primary completion:** 2026-02-13
- **Final completion:** 2026-02-13
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2026-04-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01887938

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01887938, "An Efficacy and Safety Study of HGT-1110 in Participants With Metachromatic Leukodystrophy". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT01887938. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*